A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
2don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
4d
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Science Africa on MSN9h
HIV Treatment Options for Newborns in the OffingBy Gift BritonFor the first time, infants younger than 28 days (neonates) can safely receive Dolutegravir (DTG), one of the most effective and widely used HIV drugs worldwide.Since the World Health ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.
Montgomery Advertiser on MSN2d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback